[
  {
    "id": 81,
    "question": "Homonymous hemianopia:",
    "option_a": "(ACA) is incorrect because the anterior cerebral artery supplies medial frontal and parietal lobes and is not involved in the primary visual pathway. Option b (MCA) is also incorrect because, although the MCA supplies lateral cortex including sensorimotor areas, it generally spares the deep visual pathway structures. Option c (Anterior choroidal artery) is correct as it directly supplies the optic tract and lateral geniculate nucleus, causing homonymous hemianopia when infarcted.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "c",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nHomonymous hemianopia is a visual field defect defined by the loss of the same half of the visual field in both eyes. It arises from lesions in the retrochiasmal visual pathways (post-optic chiasm), where the processing of visual information is segregated by visual field.\n\n**Pathophysiology**\n\nThe anterior choroidal artery supplies critical components of the visual pathway including the optic tract, lateral geniculate nucleus, and portions of the internal capsule. An infarction in the territory of the anterior choroidal artery can damage these structures, leading directly to a contralateral homonymous hemianopia. Recent imaging studies and vascular research have confirmed the relevance of this arterial territory in producing isolated or predominantly visual deficits.\n\n**Clinical Correlation**\n\nPatients with infarcts in the anterior choroidal territory may present with a sudden visual field loss (contralateral homonymous hemianopia) accompanied sometimes by subtle motor or sensory deficits from internal capsule involvement. Recognizing the pattern of visual field loss helps in localizing the lesion to the post-chiasmal visual pathways.\n\n**Diagnostic Approach**\n\nThe evaluation includes formal visual field testing, neuroimaging such as a CT scan or MRI to assess for infarction, and vascular imaging (CTA or MRA) to evaluate the patency of the anterior choroidal artery. Differential diagnoses include occipital lobe infarcts (posterior cerebral artery territory) and lesions affecting the optic radiations.\n\n**Management Principles**\n\nManagement involves acute stroke protocols including rapid imaging, possible IV thrombolytic therapy if within the therapeutic window, and secondary prevention measures (antiplatelet therapy, blood pressure management, etc.). Pregnancy and lactation require careful consideration of imaging modalities (preferring noncontrast CT in emergencies) and medication safety profiles when selecting antithrombotic therapy.\n\n**Option Analysis**\n\nOption a (ACA) is incorrect because the anterior cerebral artery supplies medial frontal and parietal lobes and is not involved in the primary visual pathway. Option b (MCA) is also incorrect because, although the MCA supplies lateral cortex including sensorimotor areas, it generally spares the deep visual pathway structures. Option c (Anterior choroidal artery) is correct as it directly supplies the optic tract and lateral geniculate nucleus, causing homonymous hemianopia when infarcted.\n\n**Clinical Pearls**\n\n\u2022 Homonymous hemianopia localizes the lesion to the post-chiasmal visual pathways. \u2022 Anterior choroidal artery infarcts can also cause subtle motor deficits due to internal capsule involvement. \u2022 Rapid neuroimaging is key in acute visual deficits to distinguish stroke from other causes.\n\n**Current Evidence**\n\nCurrent stroke guidelines emphasize early identification and management of small vessel strokes. Recent studies have reinforced the importance of correlating specific visual deficits with vascular territories to guide acute management and appropriate secondary prevention strategies.",
    "exam_year": "2019",
    "exam_type": "Part I"
  },
  {
    "id": 82,
    "question": "56-year-old male with Hx of memory loss for 24 hours & asking the same question repeatedly, investigation",
    "option_a": "(CT & CTA) is correct because it meets the urgency of diagnosing acute cerebrovascular events and provides both hemorrhage exclusion and vascular assessment. Option b (MRI) while sensitive for ischemia, is less appropriate in the emergency setting due to longer scan times and possible contraindications. The marked answer (B) is therefore incorrect.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nIn the setting of an acute neurological deficit (such as memory loss and repetitive questioning) suspected to be due to a cerebrovascular event, rapid imaging is critical for timely diagnosis and management.\n\n**Pathophysiology**\n\nAcute memory loss in a 56-year-old male raises concern for ischemic events or transient ischemic attacks. The pathophysiological process involves an interruption of blood flow causing neuronal dysfunction. Early identification of hemorrhage versus ischemia is essential, as management diverges drastically between these conditions.\n\n**Clinical Correlation**\n\nPatients presenting with acute memory loss and repetitive questioning may be experiencing deficits related to ischemia in brain regions responsible for memory (e.g., hippocampal areas or other related structures). The clinical urgency is to rule out hemorrhage and to identify any vascular occlusion that might be amenable to thrombolysis or endovascular intervention.\n\n**Diagnostic Approach**\n\nThe initial imaging study should be a noncontrast CT scan to rapidly exclude hemorrhage, paired with CT angiography (CTA) to evaluate for luminal stenosis or occlusion in the cerebral or cervical arteries. Although MRI, particularly diffusion-weighted imaging, is more sensitive for early ischemic changes, it is less practical in the initial emergency setting because of its longer acquisition time and limited availability.\n\n**Management Principles**\n\nAccording to current stroke guidelines, the initial management of suspected stroke entails rapid noncontrast CT to exclude hemorrhage, followed by CTA to assess for treatable vascular occlusions. These tests determine eligibility for interventions like IV thrombolysis or mechanical thrombectomy. In scenarios involving pregnancy or lactation, imaging protocols may be adjusted to minimize radiation exposure while still providing rapid diagnostic information; noncontrast CT remains acceptable if benefit outweighs risks, and shielding methods can be used.\n\n**Option Analysis**\n\nOption a (CT & CTA) is correct because it meets the urgency of diagnosing acute cerebrovascular events and provides both hemorrhage exclusion and vascular assessment. Option b (MRI) while sensitive for ischemia, is less appropriate in the emergency setting due to longer scan times and possible contraindications. The marked answer (B) is therefore incorrect.\n\n**Clinical Pearls**\n\n\u2022 In acute stroke workup, a noncontrast CT scan is the first-line investigation to rapidly rule out hemorrhage. \u2022 CT angiography adds key vascular information that guides interventional decisions. \u2022 Time is brain: rapid imaging is crucial to preserving neurological function.\n\n**Current Evidence**\n\nRecent guidelines from the American Heart Association/American Stroke Association continue to advocate for CT/CTA as the standard first-line imaging for suspected acute stroke due to its speed, accessibility, and effectiveness in guiding emergency treatment decisions. Research consistently shows that delays in imaging can worsen outcomes in stroke management.",
    "exam_year": "2019",
    "exam_type": "Part I"
  },
  {
    "id": 83,
    "question": "Case about patient with recurrent epistaxis & Telangiectasia over- skin. - mucous membranes - retina & GIT. What to do next:",
    "option_a": "(Annual MRI brain) is not routinely indicated unless neurological symptoms develop. Option b (Regular BP check",
    "option_b": "",
    "option_c": "(ECHO) may help screen for pulmonary arteriovenous malformations but does not tackle the GI bleeding risk. Option d (Endoscopy) is the correct next step as it directly evaluates and may treat gastrointestinal telangiectasias responsible for chronic bleeding.",
    "option_d": "",
    "option_e": "",
    "correct_answer": "D",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nHereditary hemorrhagic telangiectasia (HHT) is a genetic disorder that leads to abnormal blood vessel formation. It commonly presents with telangiectasias on the skin, mucous membranes, retina, and gastrointestinal (GI) tract, as well as recurrent bleeding episodes (epistaxis).\n\n**Pathophysiology**\n\nHHT is caused by mutations (such as in ENG or ACVRL1 genes) that affect angiogenesis, leading to fragile and abnormally dilated vessels (telangiectasias and arteriovenous malformations). These vascular malformations are prone to bleeding, particularly in mucosal and gastrointestinal sites, resulting in chronic blood loss and potential anemia.\n\n**Clinical Correlation**\n\nPatients with HHT often experience recurrent spontaneous nosebleeds, and the presence of telangiectasias on the skin, retina, and especially in the GI tract points to potential sources of occult bleeding leading to iron deficiency anemia. Identifying GI lesions is crucial for targeted management.\n\n**Diagnostic Approach**\n\nDiagnostic work-up involves a combination of physical examination, family history, and endoscopic evaluation (such as an upper and lower GI endoscopy) to identify sources of GI bleeding. Differential diagnoses include other causes of GI bleeding (peptic ulcer disease, angiodysplasia, and inflammatory bowel diseases), but the presence of mucocutaneous telangiectasia strongly supports HHT.\n\n**Management Principles**\n\nManagement of HHT focuses on controlling bleeding and screening for organ involvement. For GI bleeding, endoscopy (option d) is the cornerstone of diagnosis and potential therapeutic intervention (e.g., laser coagulation). Additional management includes iron supplementation, blood transfusions for severe anemia, and sometimes systemic therapies. In pregnancy and lactation, careful management is essential to balance maternal bleeding risks with fetal safety, and endoscopic procedures are performed with appropriate sedation and monitoring.\n\n**Option Analysis**\n\nOption a (Annual MRI brain) is not routinely indicated unless neurological symptoms develop. Option b (Regular BP check-up) does not specifically address the bleeding risk or source in HHT. Option c (ECHO) may help screen for pulmonary arteriovenous malformations but does not tackle the GI bleeding risk. Option d (Endoscopy) is the correct next step as it directly evaluates and may treat gastrointestinal telangiectasias responsible for chronic bleeding.\n\n**Clinical Pearls**\n\n\u2022 HHT is strongly suggested by recurrent epistaxis combined with telangiectasias on the skin, mucous membranes, and GI tract. \u2022 Endoscopic evaluation is essential in patients with HHT who have signs of GI bleeding. \u2022 Maintaining a high index of suspicion for AVMs in multiple organ systems is crucial in HHT.\n\n**Current Evidence**\n\nRecent consensus statements and guidelines for HHT management recommend targeted screening\u2014including endoscopy\u2014for patients with symptoms suggestive of GI involvement, rather than routine annual neuroimaging or cardiac studies in asymptomatic individuals. Current research is also exploring the role of antiangiogenic therapies in reducing bleeding episodes in HHT.",
    "exam_year": "2019",
    "exam_type": "Part I"
  },
  {
    "id": 84,
    "question": "Patient with radial fracture one month ago came complaining of pain and erythema, the exam was difficult because of pain what is the dx:",
    "option_a": "Complex regional pain syndrome",
    "option_b": "Arterial insufficiency",
    "option_c": "Dejerine Roussy syndrome",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nComplex Regional Pain Syndrome (CRPS) is a chronic pain condition that commonly arises after a traumatic event, such as a fracture. It is characterized by persistent pain that is disproportionate to the initial injury, along with sensory, vasomotor, and motor disturbances.\n\n**Pathophysiology**\n\nThe underlying mechanism of CRPS involves a combination of peripheral sensitization, central nervous system changes, neurogenic inflammation, and autonomic dysregulation. Following trauma, an abnormal inflammatory response and maladaptive neuroplastic changes lead to persistent pain, swelling, and skin changes such as erythema.\n\n**Clinical Correlation**\n\nIn patients with a history of a radial fracture who later complains of severe, persistent pain, erythema, and difficulty with examination due to tenderness, CRPS is a leading diagnostic consideration. These symptoms correlate with the typical features of CRPS, such as allodynia, hyperalgesia, and trophic skin changes.\n\n**Diagnostic Approach**\n\nDiagnosis of CRPS is clinical and based on the widely accepted Budapest Criteria, which include sensory, vasomotor, sudomotor/edema, and motor/trophic findings. Differential diagnoses include arterial insufficiency (which would show diminished pulses and pallor) and post-stroke pain syndrome (Dejerine Roussy syndrome), which is associated with central nervous system lesions rather than post-traumatic changes.\n\n**Management Principles**\n\nManagement of CRPS is multimodal. First-line treatments include physical and occupational therapy to improve function and desensitize the affected limb, along with analgesics such as non-steroidal anti-inflammatory drugs (NSAIDs) and neuropathic agents (e.g., gabapentin). Second-line options include corticosteroids and nerve blocks. In refractory cases, more advanced modalities like spinal cord stimulation may be considered. In pregnancy and lactation, therapeutic decisions require careful evaluation of drug safety profiles, often favoring non-pharmacological interventions and using medications with established safety records.\n\n**Option Analysis**\n\nOption a (Complex Regional Pain Syndrome) is correct because the symptomatology\u2014persistent pain, erythema, and tactile hypersensitivity following a fracture\u2014fits with a CRPS diagnosis. Option b (Arterial insufficiency) is less likely since it typically presents with diminished pulses and pallor rather than the observed erythema and disproportionate pain. Option c (Dejerine Roussy syndrome) pertains to thalamic pain following stroke, which is unrelated to a recent fracture.\n\n**Clinical Pearls**\n\n\u2022 CRPS often develops after trauma and is marked by pain that is out of proportion to the injury. \u2022 Early mobilization and multidisciplinary management are key to improving outcomes in CRPS. \u2022 Diagnosis is clinical, using criteria such as the Budapest Criteria to guide evaluation.\n\n**Current Evidence**\n\nRecent literature emphasizes early intervention in CRPS, with a trend towards integrative pain management strategies including physical therapy, psychological support, and careful pharmacologic management. Updated guidelines strongly advocate for individualized, multimodal treatment plans to reduce chronic pain and functional impairment.",
    "exam_year": "2019",
    "exam_type": "Part I"
  },
  {
    "id": 85,
    "question": "Case of Wilson disease and features of KF ring (greenish and greyish discoloration) the most common feature:",
    "option_a": "Mania",
    "option_b": "Psychosis",
    "option_c": "Depression",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nWilson disease is an autosomal recessive disorder caused by mutations in the ATP7B gene, which leads to defective copper metabolism and toxic copper accumulation in organs such as the liver, brain, and eyes. The detection of Kayser-Fleischer (KF) rings \u2013 copper deposition in the Descemet membrane of the cornea \u2013 is a key clinical clue in patients with neurologic involvement.\n\n**Pathophysiology**\n\nDue to the ATP7B mutation, copper is not adequately excreted into bile, leading to its accumulation in various tissues. Copper deposition in the basal ganglia and frontal lobes contributes to the neuropsychiatric manifestations, while deposition in the cornea manifests as KF rings. The toxic effects of copper on neuronal metabolism and neurotransmitter pathways are thought to contribute to mood disturbances, including depression.\n\n**Clinical Correlation**\n\nPatients with Wilson disease may present with hepatic dysfunction, movement disorders, and neuropsychiatric symptoms. Among the psychiatric manifestations, depression is one of the most common, often predating overt neurological deficits. Awareness of these signs is critical for early diagnosis and treatment.\n\n**Diagnostic Approach**\n\nDiagnosis is based on a combination of findings: a low serum ceruloplasmin level, increased urinary copper excretion, evidence of copper accumulation on liver biopsy, and the presence of KF rings detected with slit-lamp examination. Differential diagnoses include other causes of psychiatric illness or movement disorders; however, the combination with hepatic dysfunction and KF ring findings is highly suggestive of Wilson disease.\n\n**Management Principles**\n\nTreatment involves copper chelation with agents such as penicillamine or trientine, zinc supplementation to block copper absorption, and sometimes dietary copper restriction. In patients presenting with neuropsychiatric symptoms, collaborative care including psychiatric management is essential. For pregnancy and lactation, penicillamine and trientine are used cautiously with dosage adjustments and close monitoring; zinc is also considered a safe option during these periods.\n\n**Option Analysis**\n\nOption A (Mania) and Option B (Psychosis) are recognized neuropsychiatric manifestations in Wilson disease but are less common than mood disturbances. Option C (Depression), which is marked, represents the most frequent psychiatric presentation, making it the correct answer.\n\n**Clinical Pearls**\n\n1. Kayser-Fleischer rings are nearly pathognomonic for Wilson disease in the presence of neurologic symptoms. 2. Depression is the most common and often early psychiatric manifestation, warranting careful evaluation in young patients with mood disturbances. 3. Early diagnosis and treatment with copper chelation can significantly improve outcomes.\n\n**Current Evidence**\n\nRecent guidelines emphasize interdisciplinary management including hepatology, neurology, and psychiatry. Advances in imaging and genetic testing have improved early detection, and current research continues to explore optimal dosing regimens for chelation therapy and alternative treatments that minimize adverse effects, especially in women of childbearing potential.",
    "exam_year": "2019",
    "exam_type": "Part I"
  },
  {
    "id": 86,
    "question": "Patient with progressive myoclonus and dementia how to confirm the diagnosis",
    "option_a": "MRI",
    "option_b": "Lactate",
    "option_c": "Muscle biopsy",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nThe clinical scenario of progressive myoclonus and dementia is characteristic of a group of disorders known as progressive myoclonic epilepsies (PMEs), among which mitochondrial disorders such as Myoclonic Epilepsy with Ragged Red Fibers (MERRF) are well recognized.\n\n**Pathophysiology**\n\nMERRF is caused by mutations in mitochondrial DNA that impair oxidative phosphorylation, leading to energy failure and the accumulation of abnormal mitochondria in skeletal muscle. This results in histopathological findings such as ragged red fibers on muscle biopsy. The energy deficiency particularly affects high-demand tissues, including the brain and muscles, contributing to myoclonic seizures, ataxia, and dementia.\n\n**Clinical Correlation**\n\nPatients typically present with myoclonic jerks, seizures, ataxia, and varying degrees of cognitive impairment. The prominence of myoclonus together with progressive dementia guides clinicians to suspect a mitochondrial etiology.\n\n**Diagnostic Approach**\n\nWhile neuroimaging such as MRI may demonstrate non-specific changes, and serum lactate levels may be elevated, the definitive diagnosis of mitochondrial disorders like MERRF is established through muscle biopsy, which reveals ragged red fibers on modified Gomori trichrome staining. Genetic testing can further support the diagnosis by identifying mitochondrial DNA mutations.\n\n**Management Principles**\n\nManagement is primarily supportive and symptomatic. Seizure control is often achieved with antiepileptic drugs (e.g., levetiracetam, clonazepam) while avoiding those that might worsen mitochondrial dysfunction. Coenzyme Q10 and other mitochondrial supplements may be considered; however, evidence is variable. In pregnancy and lactation, careful selection of antiepileptic drugs that have a better safety profile is essential, and genetic counseling is recommended due to the maternal inheritance of mitochondrial disorders.\n\n**Option Analysis**\n\nOption A (MRI) is non-specific for diagnosing mitochondrial disorders because while it may show structural or signal abnormalities, it does not provide definitive diagnostic evidence. Option B (Lactate) can be supportive if elevated, but it is neither specific nor confirmatory. Option C (Muscle biopsy) is the gold standard for confirming the diagnosis of MERRF because it directly demonstrates the characteristic pathological findings (ragged red fibers). Therefore, Option C is the correct answer.\n\n**Clinical Pearls**\n\n1. In suspected mitochondrial disorders with myoclonus and dementia, muscle biopsy remains the cornerstone of diagnosis. 2. Elevated lactate levels support the diagnosis but are not confirmatory. 3. MRI findings are typically non-specific in mitochondrial myopathies.\n\n**Current Evidence**\n\nRecent studies continue to validate the role of muscle biopsy and genetic analysis in diagnosing mitochondrial diseases. Although biochemical markers such as lactate remain a useful adjunct, the combination of histological findings and mitochondrial DNA sequencing is recommended by current neuromuscular guidelines for a definitive diagnosis.",
    "exam_year": "2019",
    "exam_type": "Part I"
  },
  {
    "id": 87,
    "question": "Patient with early-onset Alzheimer what is the gene (presenilin not in the choices):",
    "option_a": "APP",
    "option_b": "APOE",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nEarly-onset Alzheimer\u2019s disease (AD) is a hereditary form of dementia that typically presents before the age of 65. It is most commonly associated with mutations in genes involved in amyloid precursor protein (APP) processing, including APP itself as well as presenilin genes (PSEN1 and PSEN2).\n\n**Pathophysiology**\n\nMutations in the APP gene lead to abnormal processing of amyloid precursor protein, resulting in the formation of beta-amyloid plaques. These plaques disrupt neuronal function, trigger inflammatory responses, and contribute to neurodegeneration. When presenilin mutations are not available as an option, APP mutations are implicated as a critical pathogenic factor in early-onset AD.\n\n**Clinical Correlation**\n\nPatients with early-onset AD present with memory loss, impaired judgment, and changes in behavior. The genetic underpinning in these cases often leads to more aggressive progression of the disease compared to sporadic, late-onset Alzheimer\u2019s.\n\n**Diagnostic Approach**\n\nDiagnosis is primarily clinical, supported by neuroimaging (e.g., MRI, PET scans) and neuropsychological testing. Genetic testing for mutations in APP, PSEN1, and PSEN2 is used in familial cases. Differential diagnoses include frontotemporal dementia and other hereditary dementias, but the pattern of amyloid plaque deposition favors Alzheimer\u2019s.\n\n**Management Principles**\n\nManagement includes the use of cholinesterase inhibitors and NMDA receptor antagonists (e.g., memantine) to slow the progression of cognitive decline. In early-onset cases, genetic counseling is vital. During pregnancy and lactation, careful evaluation of medication safety is necessary; some cognitive enhancers may require dose adjustments or close monitoring.\n\n**Option Analysis**\n\nOption A (APP) is correct as mutations in the APP gene can cause early-onset Alzheimer\u2019s disease. Option B (APOE) is associated predominantly as a risk factor for the more common late-onset form rather than being a direct causative mutation in early-onset cases, making Option A the best choice given the exclusion of presenilin genes.\n\n**Clinical Pearls**\n\n1. APP mutations are a recognized cause of familial early-onset Alzheimer\u2019s disease. 2. APOE is a risk factor for late-onset Alzheimer\u2019s, not a determinative gene in early-onset cases. 3. Early genetic diagnosis can be invaluable for family counseling and management planning.\n\n**Current Evidence**\n\nRecent research supports the role of APP mutations in the pathogenesis of early-onset AD, and evolving therapies targeting amyloid-beta deposition are a focus of current clinical trials. Genetic testing has become more accessible, supporting its use in selected familial cases.",
    "exam_year": "2019",
    "exam_type": "Part I"
  },
  {
    "id": 88,
    "question": "Brain MRI is showing unilateral watershed infarction what is the mechanism",
    "option_a": "ICA stenosis",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nWatershed infarcts occur in the areas of the brain that lie at the border zones between the major cerebral arterial territories. They are particularly vulnerable to reductions in perfusion, and unilateral involvement typically suggests a localized vascular abnormality.\n\n**Pathophysiology**\n\nIn cases of unilateral watershed infarction, the most common mechanism is severe stenosis of the internal carotid artery (ICA) on the affected side. The stenosis leads to reduced cerebral blood flow in the distal territories, especially under conditions of systemic hypotension or increased metabolic demand, causing ischemia in the border zone regions.\n\n**Clinical Correlation**\n\nPatients with unilateral watershed infarcts may present with focal neurologic deficits that do not conform strictly to a single major arterial distribution. This pattern should prompt investigation into carotid artery disease as an underlying etiology.\n\n**Diagnostic Approach**\n\nEvaluation typically includes neuroimaging with MRI to identify the pattern of infarction and vascular imaging (such as CT angiography, MR angiography, or carotid duplex ultrasound) to assess for ICA stenosis. Differential diagnoses include embolic infarcts and small vessel disease, but the watershed pattern is characteristic of hypoperfusion due to proximal stenosis.\n\n**Management Principles**\n\nFirst-line management involves optimizing cerebral perfusion and addressing the underlying vascular pathology. Antiplatelet therapy and risk factor modification (control of hypertension, hyperlipidemia, and diabetes) are recommended. In selected patients with significant symptomatic carotid stenosis, revascularization procedures (carotid endarterectomy or stenting) may be considered. In pregnancy and lactation, medical management is generally preferred with careful risk\u2013benefit analysis regarding any invasive intervention.\n\n**Option Analysis**\n\nOption A (ICA stenosis) is correct as it directly relates to the hemodynamic compromise seen in unilateral watershed infarctions. The other options, though not listed, could include global hypotension which typically causes bilateral infarcts, or embolic phenomena which look different on imaging.\n\n**Clinical Pearls**\n\n1. Unilateral watershed infarcts should raise suspicion for ipsilateral carotid artery disease. 2. Careful vascular imaging is essential to differentiate watershed infarcts from other types of stroke. 3. Medical management of ICA stenosis includes antiplatelet therapy and risk factor control, with revascularization reserved for selected cases.\n\n**Current Evidence**\n\nRecent guideline updates emphasize the importance of early carotid imaging for patients with suspected watershed infarcts. Studies continue to refine criteria for carotid revascularization, and the use of less invasive imaging techniques has improved diagnosis and management. In pregnant patients, a conservative approach is typically favored unless the risk of stroke significantly outweighs procedural risks.",
    "exam_year": "2020",
    "exam_type": "Part I",
    "image_url": "page_24.png"
  },
  {
    "id": 89,
    "question": "Patient underwent carotid endarterectomy due to severe symptomatic stenosis and the next day he deteriorated, brain CT is showing right frontal cortical SAH. What is the cause?",
    "option_a": "Hyperperfusion",
    "option_b": "Rupture of undiagnosed aneurysm",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nCarotid endarterectomy is performed to eliminate high\u2010grade carotid stenosis and reduce stroke risk. However, rapid restoration of blood flow in chronically hypoperfused brain tissue can lead to a dysregulated vasodilatory response, resulting in cerebral hyperperfusion syndrome. This syndrome may manifest with headache, neurological deterioration, and imaging findings such as cortical subarachnoid hemorrhage (SAH).\n\n**Pathophysiology**\n\nDuring chronic hypoperfusion, cerebral vessels undergo maximal vasodilation to maintain adequate blood flow. After revascularization, the sudden increase in perfusion pressure overwhelms the impaired autoregulation, leading to leakage of blood components and sometimes frank hemorrhage in the cortical regions. Recent studies emphasize that hyperperfusion can lead to blood\u2013brain barrier disruption and vasogenic edema, culminating in cortical SAH.\n\n**Clinical Correlation**\n\nPatients usually present with acute neurological deterioration, headache, and sometimes seizures after carotid revascularization. In this case, the right frontal cortical SAH on CT scan corresponds with the territory affected by the altered hemodynamics.\n\n**Diagnostic Approach**\n\nPrimary imaging is non\u2010contrast CT to detect hemorrhagic changes. Differential diagnoses include rupture of a previously undiagnosed intracranial aneurysm or other procedural complications. However, the timing and pattern (cortical SAH in the revascularized territory) point toward hyperperfusion syndrome. Additional investigations may include MRI and angiography to further assess cerebral vasculature if needed.\n\n**Management Principles**\n\nThe cornerstone of management is strict blood pressure control using intravenous antihypertensives (e.g., labetalol, nicardipine) immediately after diagnosis. Supportive care in an intensive care setting is indicated. For pregnant or lactating patients, medications with established safety profiles (e.g., labetalol) should be preferred, and dosing should be carefully monitored due to altered hemodynamic status.\n\n**Option Analysis**\n\nOption A (Hyperperfusion) correctly identifies the etiology as the rapid increase in cerebral blood flow overwhelming impaired autoregulation. Option B (Rupture of undiagnosed aneurysm) is less likely given the timing and CT pattern; aneurysmal SAH typically presents with diffuse cisternal blood rather than localized cortical hemorrhage.\n\n**Clinical Pearls**\n\n1. Always consider hyperperfusion syndrome in patients who deteriorate shortly after carotid revascularization. 2. Early blood pressure management can significantly reduce morbidity. 3. Cortical SAH in the postoperative period is more suggestive of reperfusion injury than aneurysmal rupture.\n\n**Current Evidence**\n\nRecent guidelines emphasize rigorous blood pressure control post-revascularization and advocate for standardized protocols in monitoring for hyperperfusion syndrome. Contemporary research continues to explore biomarkers that could predict which patients are at increased risk of this complication.",
    "exam_year": "2020",
    "exam_type": "Part I",
    "image_url": "page_2.png"
  },
  {
    "id": 90,
    "question": "Locked in syndrome",
    "option_a": "Ventral pons",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nLocked-in syndrome is a neurological disorder characterized by quadriplegia and anarthria with preserved consciousness, typically resulting from a lesion that disrupts motor pathways while sparing the reticular activating system.\n\n**Pathophysiology**\n\nThe ventral part of the pons houses the corticospinal and corticobulbar tracts. An infarct or hemorrhage in this region, commonly due to basilar artery occlusion, interrupts these tracts, rendering the patient 'locked-in.' Despite extensive paralysis, vertical eye movements and blinking are usually preserved because the midbrain structures controlling these functions remain intact.\n\n**Clinical Correlation**\n\nClinically, patients appear awake and alert but are unable to move or speak, communicating only through vertical eye movements. This is a direct consequence of damage to the ventral pons, where motor output is disrupted while sensory and consciousness pathways are spared.\n\n**Diagnostic Approach**\n\nDiagnosis is based on clinical examination supported by neuroimaging (MRI is particularly sensitive). The differential includes coma or severe motor deficits from diffuse brain injury; however, preserved consciousness and specific eye movement patterns are key clues.\n\n**Management Principles**\n\nManagement is supportive and includes intensive care, prevention of complications (e.g., infections, thromboembolism), and rehabilitation. Early involvement of a multi-disciplinary team is essential. In pregnant or lactating patients, supportive care remains the mainstay with additional considerations for maternal and fetal monitoring if required.\n\n**Option Analysis**\n\nOption A (Ventral pons) is correct because lesions in this area are classically responsible for locked-in syndrome. Other potential locations would not explain the classic preservation of consciousness with complete motor deficit.\n\n**Clinical Pearls**\n\n1. Preserved vertical eye movements with complete paralysis strongly suggests locked-in syndrome. 2. Vascular lesions of the ventral pons, often due to basilar artery occlusion, are the most common cause. 3. Despite profound deficits, patients are fully conscious and should be treated with respect and efforts to communicate.\n\n**Current Evidence**\n\nCurrent research focuses on innovative rehabilitation techniques and augmentative communication strategies for locked-in syndrome, as well as on developing neuroprotective strategies during the acute phase to minimize pontine damage.",
    "exam_year": "2020",
    "exam_type": "Part I"
  }
]